全文获取类型
收费全文 | 3617856篇 |
免费 | 255356篇 |
国内免费 | 9469篇 |
专业分类
耳鼻咽喉 | 48817篇 |
儿科学 | 119957篇 |
妇产科学 | 99375篇 |
基础医学 | 508272篇 |
口腔科学 | 102115篇 |
临床医学 | 331242篇 |
内科学 | 705206篇 |
皮肤病学 | 85355篇 |
神经病学 | 292699篇 |
特种医学 | 137173篇 |
外国民族医学 | 941篇 |
外科学 | 540167篇 |
综合类 | 77794篇 |
现状与发展 | 8篇 |
一般理论 | 1393篇 |
预防医学 | 276962篇 |
眼科学 | 83850篇 |
药学 | 264047篇 |
12篇 | |
中国医学 | 7987篇 |
肿瘤学 | 199309篇 |
出版年
2019年 | 28661篇 |
2018年 | 40853篇 |
2017年 | 31137篇 |
2016年 | 35434篇 |
2015年 | 40139篇 |
2014年 | 55553篇 |
2013年 | 83023篇 |
2012年 | 111908篇 |
2011年 | 118453篇 |
2010年 | 70936篇 |
2009年 | 67339篇 |
2008年 | 110299篇 |
2007年 | 117421篇 |
2006年 | 119041篇 |
2005年 | 114183篇 |
2004年 | 109874篇 |
2003年 | 105668篇 |
2002年 | 102066篇 |
2001年 | 175749篇 |
2000年 | 179888篇 |
1999年 | 151284篇 |
1998年 | 42991篇 |
1997年 | 37867篇 |
1996年 | 37995篇 |
1995年 | 36843篇 |
1994年 | 33680篇 |
1993年 | 31562篇 |
1992年 | 117097篇 |
1991年 | 112938篇 |
1990年 | 109314篇 |
1989年 | 105609篇 |
1988年 | 96568篇 |
1987年 | 94593篇 |
1986年 | 88806篇 |
1985年 | 84786篇 |
1984年 | 63206篇 |
1983年 | 53634篇 |
1982年 | 31459篇 |
1981年 | 28040篇 |
1979年 | 55909篇 |
1978年 | 39251篇 |
1977年 | 33402篇 |
1976年 | 31142篇 |
1975年 | 32956篇 |
1974年 | 39314篇 |
1973年 | 37577篇 |
1972年 | 35093篇 |
1971年 | 32572篇 |
1970年 | 30100篇 |
1969年 | 28767篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
991.
D Bild L S Geiss S M Teutsch B Gabella B A Hudspeth R M Schubert C W Gollmar D J Kaplan F A Connell J C Will 《Journal of clinical epidemiology》1988,41(10):999-1006
The pilot study for a sentinel health events surveillance system for deaths among persons under age 45 with diabetes was conducted in six states in 1984 and 1985. Two hundred and thirty-three events were identified. Information from death certificates, physicians, and families revealed that 22% died from acute complications of diabetes and 53% from chronic complications. Blood pressure measurement and urinalysis testing had been performed in the last year for almost all of the decedents, but other preventive practices were reported less frequently. Hypertension was present in 57% and of those, was not controlled in 73%. Forty-four percent were cigarette smokers at the time of death. Agreement between physicians and families was generally higher for clinical conditions than for care practices. This surveillance system appears to yield information about the health care of persons with diabetes not readily available from other sources, although modifications may be necessary before implementation. 相似文献
992.
M D Silverstein D A Albert N M Hadler M W Ropes 《Journal of clinical epidemiology》1988,41(7):623-633
993.
SRIVASTAVA Z. I.; MATHUR N.; RASTOGI S. K.; GUPTA B. N. 《Occupational medicine (Oxford, England)》1988,38(4):134-136
Eighty-nine cases of chronic bronchitis were matched against167 asymptomatic controls from the glass bangle industry ofFirozabad. Factors of age, social status, smoking habit andduration of exposure were studied. Duration of exposure wasfound to be a factor contributing significantly to the causationof disease.
Requests for reprints should be addressed to: Dr B. N. Gupta, Division of Epidemilogy, Industrial Toxicology Research Centre, Mahatma Gandhi Marg, Lucknow P.O. Box 80, 226001, India 相似文献
994.
995.
996.
A Watanabe K Ohizumi M Motomiya K Takeuchi T Yoshida S Ida Y Miura K Nishioka Y Tanno T Takishima 《The Japanese journal of antibiotics》1990,43(8):1392-1401
We evaluated the therapeutic efficacy of miconazole (MCZ, Florid-F inj.), a new antifungal agent for parenteral use, in deep-seated fungal infections of respiratory tract system. A daily dose of 400-1,800 mg of MCZ was given intravenously for 12-38 days (mean: 23.4 days) to 7 patients: 2 patients with pulmonary aspergillosis, 1 patient with bronchial aspergillosis, 1 patient with pulmonary candidiasis and 3 patients with candidemia. One additional patient with pulmonary aspergillosis received three instillations of 20 mg of MCZ into the thoracic cavity. The clinical effects were excellent in 1, good in 4 and poor in 3 patients. The efficacy rate was 100% in 5 cases with respiratory fungal infections but 3 cases with candidemia did not respond well to the treatment. Four strains each of Aspergillus sp. and Candida sp. were identified as causative organisms. Seven of the 8 strains were eradicated by administration of MCZ. Side effects observed were irritation and heat in a leg in 1 patient, hyperlipoidemia in 2 patients and eosinophilia in 1 patient. The adverse reactions disappeared after the completion of the therapy. From the above results, we conclude that MCZ is one of the most useful antifungal agents for parenteral use as a first choice on deep-seated fungal infections in the respiratory tract. 相似文献
997.
Rik C. Schoemaker Joop M. A. van Gerven Adam F. Cohen 《Journal of pharmacokinetics and pharmacodynamics》1998,26(5):581-593
The most widely applied model relating drug concentrations to effects is the Emax
model. In practice, concentration–effect relationships often deviate from a simple linear relationship but without reaching a clear maximum because a further increase in concentration might be associated with unacceptable or distorting side effects. The parameters for the Emax
model can only be estimated with reasonable precision if the curve shows sign of reaching a maximum, otherwise both EC50
and Emax
estimates may be extremely imprecise. This paper provides a solution by introducing a new parameter (S0
) equal to Emax/EC50
that can be used to characterize potency adequately even if there are no signs of a clear maximum. Simulations are presented to investigate the nature of the new parameter and published examples are used as illustration. 相似文献
998.
Y Nishizawa T Shoji S Tanaka M Yamashita A Morita M Emoto T Tabata T Inoue H Morii 《American journal of kidney diseases》1998,31(4):655-661
Leptin is a newly found hormone secreted by adipocytes that regulates food intake, thermogenesis, and body fat. We measured plasma leptin levels in 103 patients with chronic renal failure treated by hemodialysis and 167 age- and gender-matched healthy control subjects to examine the impact of renal failure on plasma leptin levels and the influence of leptin on body composition measured by dual-energy X-ray absorptiometry. Hemodialysis patients showed a significant decrease in both body fat mass and lean body mass compared with those of the control subjects. Plasma leptin was significantly elevated in the hemodialysis group over the controls. In both groups, leptin was higher in female than male subjects, and it correlated positively with percent body fat. The subjects were divided into six categories according to percent body fat, and plasma leptin levels were compared between the two groups in the same category. Leptin of hemodialysis patients was significantly higher than that of the control subjects in the percent body fat categories of 30 or greater, whereas there was no statistically significant difference in leptin concentrations in the lower percent body fat categories. This was also true in the comparison in each gender, and leptin levels in female subjects showed a more remarkable difference between the hemodialysis and control groups in obese categories. Multiple regression analysis in all subjects indicated that plasma leptin levels were independently affected by percent body fat, plasma insulin concentration, gender, and renal failure. The positive impact of renal failure on leptin remained significant in the subjects with percent body fat of 30 or greater in the multiple regression model, whereas it was no longer significant in the remaining lean subjects. In multiple regression analysis of factors affecting fat mass index and lean mass index, leptin level was selectively associated with fat mass index, but not with lean mass index, regardless of percent body fat ranges. These results indicate that renal failure is an important factor affecting plasma leptin levels, especially in obese female subjects, and that hyperleptinemia was closely related to fat mass but not to lean body mass in hemodialysis patients. 相似文献
999.
Juin Fok-Seang Linda C. Smith-Thomas Sally Meiners Elizabeth Muir Jian-Sheng Du Elizabeth Housden Alan R. Johnson Andreas Faissner Herbert M. Geller Roger J. Keynes John H. Rogers James W. Fawcett 《Brain research》1995,689(2):207
The adult mammalian central nervous system (CNS) lacks the capacity to support axonal regeneration. There is increasing evidence to suggest that astrocytes, the major glial population in the CNS, may possess both axon-growth promoting and axon-growth inhibitory properties and the latter may contribute to the poor regenerative capacity of the CNS. In order to examine the molecular differences between axon-growth permissive and axon-growth inhibitory astrocytes, a panel of astrocyte cell lines exhibiting a range of axon-growth promoting properties was generated and analysed. No clear correlation was found between the axon-growth promoting properties of these astrocyte cell lines with: (i) the expression of known neurite-outgrowth promoting molecules such as laminin, fibronectin andN-cadherin; (ii) the expression of known inhibitory molecules such tenascin and chondroitin sulphate proteoglycan; (iii) plasminogen activator and plasminogen activator inhibitor activity; and (iv) growth cone collapsing activity. EM studies on aggregates formed from astrocyte cell lines, however, revealed the presence of an abundance of extracellular matrix material associated with the more inhibitory astrocyte cell lines. When matrix deposited by astrocyte cell lines was assessed for axon-growth promoting activity, matrix from permissive lines was found to be a good substrate, whereas matrix from the inhibitory astrocyte lines was a poor substrate for neuritic growth. Our findings, taken together, suggest that the functional differences between the permissive and the inhibitory astrocyte cell lines reside largely with the ECM. 相似文献
1000.